Renaissance Technologies’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Renaissance Technologies’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-90,700	Closed	-$2.21M	–	3533
2015 Q2	$2.21M	Buy	+90,700	New	+$2.17M	0.01%	2001
2015 Q1	–	Sell	-17,000	Closed	-$427K	–	3469
2014 Q4	$427K	Buy	+17,000	New	+$499K	﹤0.01%	2481
2014 Q1	–	Sell	-98,500	Closed	-$2.5M	–	3154
2013 Q4	$2.5M	Buy	98,500 +41,900	+74%	+$946K	0.01%	1628
2013 Q3	$1.16M	Buy	56,600 +46,400	+455%	+$1.03M	﹤0.01%	1942
2013 Q2	$214K	Buy	+10,200	New	+$182K	﹤0.01%	2505

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies's SGNT Position: Q3 2015 in Review

Renaissance Technologies sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 90,700 shares — an estimated $2.21M sold.

Renaissance Technologies first reported a position in SGNT in Q2 2013 and held it in 5 quarters. The position peaked at $2.5M in Q4 2013. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

Renaissance Technologies reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Renaissance Technologies sold 90,700 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $2.21M.
Renaissance Technologies first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
Renaissance Technologies's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.5M in Q4 2013.
127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.